The U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
.
For about two decades, Botox, now sold by AbbVie Inc., has dominated the aesthetic-drug market it helped pioneer, racking up tens of billions of dollars in sales and successfully fending off challengers.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA Approves Durvalumab Plus Chemo for Biliary Tract CancerThe immune checkpoint inhibitor is already approved for use in lung cancer. Now it is also approved for use in combination with chemotherapy for locally advanced or metastatic biliary tract cancer.
続きを読む »
United Airlines may end JFK service without more flightsUnited Airlines has warned the FAA if it doesn't get approved for more flights, it will discontinue service to New York's JFK Airport in October.
続きを読む »
The worldwide water-lifting power of plants is enormousThe power expended per year by the world’s plants via evaporation rivals the amount of power generated by all hydroelectric dams, a new study suggests.
続きを読む »
Samsung flips off the iPhone 14: ‘Let us know when it folds’After the Apple Event revealed new iPhones and AirPods, rival smartphone maker Samsung went viral with a snarky tweet
続きを読む »
Toyota Tundra Sales Outpacing Every Pickup Truck from DetroitStill, though sales of the all-new, full-size, off-road-ready truck from Toyota are up, a sizable gap with domestic rivals remains.
続きを読む »
Autocar magazine 7 September 2022: on sale now | AutocarIt's Wednesday, which means there's a brand new issue of Autocar on sale! This week we drive the powerful Range Rover Sport and the new, reinvented Volkswagen ID Buzz 👀 Get your copy now!
続きを読む »